Regeneron advances antitrust lawsuit against Novartis with appeals court's backing
Fierce Pharma
MARCH 19, 2024
Did Novartis break U.S. antitrust laws in the storied Eylea-Lucentis rivalry? Thanks to an appeals court ruling, Regeneron has another chance to lay out its argument. | Did Novartis break U.S. antitrust laws in the storied Eylea-Lucentis rivalry?
Let's personalize your content